Molecular features and vulnerabilities of recurrent chordomas

BACKGROUND: Tumor recurrence is one of the major challenges in clinical management of chordoma. Despite R0-resection, approximately 50% of chordomas recur within ten years after initial surgery. The underlying molecular processes are poorly understood resulting in the lack of associated therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Seeling, Carolin, Lechel, André, Svinarenko, Michael, Möller, Peter, Barth, Thomas F. E., Mellert, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325178/
https://www.ncbi.nlm.nih.gov/pubmed/34330313
http://dx.doi.org/10.1186/s13046-021-02037-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325178/
https://www.ncbi.nlm.nih.gov/pubmed/34330313
http://dx.doi.org/10.1186/s13046-021-02037-y

Ejemplares similares